Structure of T cell epitopes a decisive factor in natural HIV control, study finds
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
Squeezing cells to cure diseases
Startup SQZ Biotech aims to open a new path in immunotherapy with its cell-compressing technique.
A single-injection vaccine for the polio virus
Nanoparticles could offer a new way to help eradicate the disease worldwide.
MIT Medical shatters one-day flu shot record
This year’s clinic lived up to its reputation as one of the most efficient operations at MIT.
Deploying therapeutic payloads to cells
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.
Progress toward a Zika vaccine
Researchers program RNA nanoparticles that could protect against the virus.
MIT undertakes Grand Challenge for innovation in global vaccine manufacturing
Bill and Melinda Gates Foundation awards MIT, University College London, and University of Kansas $17.6M for development and production of low-cost vaccines.
Nearly 5,000 shots given at first campus flu clinic of 2016
Second clinic to take place Thursday, Oct. 20, at the Stratton Student Center.
Benefiting human health through engineering
PhD student Anasuya Mandal’s microneedle device could painlessly monitor the immune system.
Engineers design programmable RNA vaccines
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
Freshly squeezed vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Q&A: Seth Mnookin on vaccination and public health
"It's far easier to scare people than it is to reassure them," MIT researcher and author says.
Evaluating strategies for HIV vaccination
Study yields insight into generating antibodies that target different strains of HIV.
3 Questions: Seth Mnookin on research to encourage vaccination
MIT professor co-authors AAAS report calling for dedicated research on vaccination decisions.